DRREDDY.NS Balance Sheet
Dr. Reddy's Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Property, Plant and Equipment | N/A | N/A | N/A | N/A | N/A | ₹56.54 Bn | ₹62.49 Bn | ₹72.98 Bn | ₹100.78 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | N/A | N/A | N/A | N/A | N/A | ₹9.75 Bn | ₹13.51 Bn | ₹23.99 Bn | ₹14.60 Bn | CapitalWorkInProgress |
| Goodwill | N/A | N/A | N/A | N/A | N/A | ₹5.47 Bn | ₹5.50 Bn | ₹13.14 Bn | ₹14.80 Bn | Goodwill |
| Other Intangible Assets | N/A | N/A | N/A | N/A | N/A | ₹30.18 Bn | ₹36.27 Bn | ₹96.14 Bn | ₹105.06 Bn | OtherIntangibleAssets |
| Non-current Investments | N/A | N/A | N/A | N/A | N/A | ₹0.66 Bn | ₹1.06 Bn | ₹2.39 Bn | ₹8.94 Bn | NoncurrentInvestments |
| Other Non-current Assets | N/A | N/A | N/A | N/A | N/A | ₹0.28 Bn | ₹5.09 Bn | ₹2.76 Bn | ₹4.48 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | N/A | N/A | N/A | N/A | N/A | ₹115.91 Bn | ₹140.59 Bn | ₹244.09 Bn | ₹279.44 Bn | NoncurrentAssets |
| Inventories | N/A | N/A | N/A | N/A | N/A | ₹48.67 Bn | ₹63.55 Bn | ₹71.08 Bn | ₹76.53 Bn | Inventories |
| Trade Receivables | N/A | N/A | N/A | N/A | N/A | ₹72.48 Bn | ₹80.30 Bn | ₹90.42 Bn | ₹101.23 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | N/A | N/A | N/A | N/A | N/A | ₹5.78 Bn | ₹7.11 Bn | ₹14.65 Bn | ₹15.37 Bn | CashAndCashEquivalents |
| Current Investments | N/A | N/A | N/A | N/A | N/A | ₹44.50 Bn | ₹44.05 Bn | ₹33.31 Bn | ₹38.23 Bn | CurrentInvestments |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | ₹15.12 Bn | ₹20.18 Bn | ₹27.07 Bn | ₹29.89 Bn | OtherCurrentAssets |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | ₹206.94 Bn | ₹248.05 Bn | ₹250.18 Bn | ₹301.79 Bn | CurrentAssets |
| Total Assets | N/A | N/A | N/A | N/A | N/A | ₹322.85 Bn | ₹388.64 Bn | ₹494.27 Bn | ₹581.23 Bn | Assets |
| Equity Share Capital | N/A | N/A | N/A | N/A | N/A | ₹0.83 Bn | ₹0.83 Bn | ₹0.83 Bn | ₹0.83 Bn | EquityShareCapital |
| Other Equity | N/A | N/A | N/A | N/A | N/A | ₹232.03 Bn | ₹281.71 Bn | ₹334.66 Bn | ₹378.08 Bn | OtherEquity |
| Equity Attributable to Owners | N/A | N/A | N/A | N/A | N/A | ₹232.86 Bn | ₹282.55 Bn | ₹335.50 Bn | ₹378.92 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | N/A | N/A | ₹0.00 Bn | ₹3.78 Bn | ₹3.39 Bn | NonControllingInterest |
| Total Equity | N/A | N/A | N/A | N/A | N/A | ₹232.86 Bn | ₹282.55 Bn | ₹339.27 Bn | ₹382.31 Bn | Equity |
| Long-term Borrowings | N/A | N/A | N/A | N/A | N/A | ₹1.28 Bn | ₹3.80 Bn | ₹3.80 Bn | ₹0.00 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | N/A | N/A | N/A | N/A | N/A | ₹4.27 Bn | ₹10.21 Bn | ₹24.65 Bn | ₹31.45 Bn | NoncurrentLiabilities |
| Short-term Borrowings | N/A | N/A | N/A | N/A | N/A | ₹12.19 Bn | ₹12.72 Bn | ₹38.05 Bn | ₹62.94 Bn | BorrowingsCurrent |
| Trade Payables | N/A | N/A | N/A | N/A | N/A | ₹22.68 Bn | ₹26.14 Bn | ₹26.48 Bn | ₹30.38 Bn | TradePayablesCurrent |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | ₹12.86 Bn | ₹11.44 Bn | ₹13.19 Bn | ₹11.92 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | ₹85.72 Bn | ₹95.88 Bn | ₹130.34 Bn | ₹167.47 Bn | CurrentLiabilities |
| Total Equity and Liabilities | N/A | N/A | N/A | N/A | N/A | ₹322.85 Bn | ₹388.64 Bn | ₹494.27 Bn | ₹581.23 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from DRREDDY.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).